Gainers

• Silexion Therapeutics (NASDAQ:SLXN) shares moved upwards by 147.2% to $0.67 during Wednesday's pre-market session. The company's market cap stands at $1.0 million. The company's, Q1 earnings came out 3 days ago.
• Jupiter Neurosciences (NASDAQ:JUNS) stock increased by 106.25% to $0.66. The market value of their outstanding shares is at $11.6 million. As per the news, the Q1 earnings report came out 4 days ago.
• BiomX (AMEX:PHGE) shares increased by 41.76% to $0.53. The company's market cap stands at $3.7 million.
• Immunovant (NASDAQ:IMVT) stock rose 28.18% to $33.7. The company's market cap stands at $5.3 billion. As per the news, the Q4 earnings report came out today.
• China SXT Pharmaceuticals (NASDAQ:SXTC) stock increased by 12.9% to $1.75. The market value of their outstanding shares is at $6.9 million.
• OmniAb (NASDAQ:OABI) stock moved upwards by 10.97% to $2.63. The market value of their outstanding shares is at $343.5 million.

Losers

• Annovis Bio (NYSE:ANVS) stock fell 17.5% to $1.6 during Wednesday's pre-market session. The market value of their outstanding shares is at $67.2 million. The company's, Q1 earnings came out 3 days ago.
• Virax Biolabs Group (NASDAQ:VRAX) stock declined by 17.49% to $0.25. The company's market cap stands at $2.2 million.
• Sunshine Biopharma (NASDAQ:SBFM) stock decreased by 17.26% to $0.36. The company's market cap stands at $2.2 million.
• Wellgistics Health (NASDAQ:WGRX) shares declined by 16.55% to $0.14. The market value of their outstanding shares is at $21.2 million. The company's, Q1 earnings came out yesterday.
• Purple Biotech (NASDAQ:PPBT) shares declined by 14.82% to $2.99. The company's market cap stands at $3.2 million. As per the press release, Q1 earnings came out 3 days ago.
• GlucoTrack (NASDAQ:GCTK) shares decreased by 13.47% to $0.48. The company's market cap stands at $2.0 million. As per the press release, Q1 earnings came out 4 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.